Estrogen receptor (ER)-β, but not ER-α, is present in thyroid vessels:: Immunohistochemical evaluations in multinodular Goiter and papillary thyroid carcinoma

被引:24
|
作者
Ceresini, Graziano
Morganti, Simonetta
Graiani, Virna
Saccani, Maria
Milli, Bruna
Usberti, Elisa
Valenti, Giorgio
Ceda, Gian Paolo
Corcione, Luigi
机构
[1] Univ Parma, Dept Internal Med & Biomed Sci, Parma, Italy
[2] Univ Parma, Dept Pathol, Parma, Italy
关键词
D O I
10.1089/thy.2006.16.1215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Estrogen receptors (ERs) have been demostrated in the vessel structures of several systems. Little is known on the presence of ERs in the thyroid vessels. Design: We immunohistochemically evaluated both ER-alpha( and ER-beta immunoreactivity (IR) in both vascular and follicular thyroid cells in tissue samples from 17 cases of multinodular goiter (MNG) and 17 cases of papillary thyroid carcinoma (PTC). Main Outcome: ER-alpha IR was undetectable in either tissue examined. In 100% of MNG samples, nuclear ER-beta IR was detected in both endothelial and follicular cells. In PTC samples, endothelial nuclear ER-beta IR was found in 100% of cases, whereas the nuclear staining of follicular cells was found in 83% of cases. The intensity of staining of the endothelial ER-beta IR was comparable between MNG and PTC. However, when follicular cells were considered, a tendency toward a decrease in nuclear staining and a significant increase in cytoplasmic staining were found in PTC lesions as compared to MNG. Conclusions: This study demonstrated that ER-beta, but not ER-alpha, IR is present in the endothelium of thyroid vessels. Furthermore, although data need to be confirmed in larger observations, these results suggest the lack of differences in the pattern of vascular ER-beta IR between MNG and PTC.
引用
收藏
页码:1215 / 1220
页数:6
相关论文
共 50 条
  • [41] A Germline Mutation (A339V) in Thyroid Transcription Factor-1 (TITF-1/NKX2.1) in Patients With Multinodular Goiter and Papillary Thyroid Carcinoma
    Ngan, Elly S. W.
    Lang, Brian H. H.
    Liu, Tingting
    Shum, Cathy K. Y.
    So, Man-Ting
    Lau, Danny K. C.
    Leon, Thomas Y. Y.
    Cherny, Stacey S.
    Tsai, Sophia Y.
    Lo, Chung-Yau
    Khoo, Ui-Soon
    Tam, Paul K. H.
    Garcia-Barcelo, Maria-Merce
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (03) : 162 - 175
  • [42] Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions
    Machairas, Nikolaos
    Kostakis, Ioannis D.
    Prodromidou, Anastasia
    Stamopoulos, Paraskevas
    Feretis, Themistoklis
    Garoufalia, Zoe
    Damaskos, Christos
    Tsourouflis, Gerasimos
    Kouraklis, Gregory
    [J]. ENDOCRINE RESEARCH, 2017, 42 (04) : 311 - 317
  • [43] Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker for premalignant lesions
    Rody, A
    Holtrich, U
    Solbach, C
    Kourtis, K
    von Minckwitz, G
    Engels, K
    Kissler, S
    Gätje, R
    Karn, T
    Kaufmann, M
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (04) : 903 - 916
  • [44] Immunohistochemical correlation of thyroid hormone receptors (TR), retinoid x receptor (RXR), peroxisome proliferators-activated receptor (PPAR), the vitamin D receptor (VDR) and estrogen-/progesterone receptor (ER/PR) in breast carcinoma
    Ditsch, N.
    Mayr, D.
    Lenhard, M.
    Kolben, T.
    Strauss, C.
    Gallwas, J.
    Himsl, J.
    Weissenbacher, T.
    Harbeck, N.
    Friese, K.
    Jeschke, U.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (07) : P55 - P55
  • [45] THYROID STIMULATING HORMONE LEVELS CORRELATE WITH ESTROGEN-RECEPTOR (ER) STATUS OF HUMAN-BREAST CANCER
    REIMER, R
    HARDESTY, I
    KUMAR, M
    SHEELER, L
    GREENSTREET, R
    LIVINGSTON, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 52 - 52
  • [46] Estrogen Receptor- and Progesterone Receptor-Positive Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: A Case Report
    Kinoshita, Yuichi
    Takasu, Kosho
    Yuri, Takashi
    Yoshizawa, Kastuhiko
    Emoto, Yuko
    Tsubura, Airo
    Shikata, Nobuaki
    [J]. CASE REPORTS IN ONCOLOGY, 2013, 6 (01): : 216 - 223
  • [47] miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor α
    Huang, Chen
    Cai, Zhaogeng
    Huang, Mingzhu
    Mao, Chaoming
    Zhang, Qifa
    Lin, Yi
    Zhang, Xiaomei
    Tang, Bi
    Chen, Yuqing
    Wang, Xiaojing
    Qian, Zhongqing
    Ye, Lei
    Peng, Yongde
    Xu, Huanbai
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : E204 - E213
  • [48] INVESTIGATIONS OF THE ESTROGEN (ER-ICA-TEST) AND THE PROGESTERONE-RECEPTOR IN THE PROSTATE AND PROSTATIC-CARCINOMA ON IMMUNOHISTOCHEMICAL BASIS
    WERNERT, N
    GERDES, J
    LOY, V
    SEITZ, G
    SCHERR, O
    DHOM, G
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1988, 412 (04) : 387 - 391
  • [49] COX-2, EGF-R, ER, PR, and HER2/neu expression in papillary thyroid carcinoma
    Debski, RF
    Ely, KA
    Sanders, ME
    Edgerton, ME
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 103A - 103A
  • [50] COX-2, EGF-R, ER, PR, and HER2/neu expression in papillary thyroid carcinoma
    Debski, RF
    Ely, KA
    Sanders, ME
    Edgerton, ME
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 103A - 103A